Search

Melissa Jean Perreira

Examiner (ID: 10386, Phone: (571)272-1354 , Office: P/1618 )

Most Active Art Unit
1618
Art Unit(s)
1618
Total Applications
1065
Issued Applications
491
Pending Applications
87
Abandoned Applications
511

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 15831885 [patent_doc_number] => 20200131224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-30 [patent_title] => Methods for Synthesis of Radionuclide Complex [patent_app_type] => utility [patent_app_number] => 16/393103 [patent_app_country] => US [patent_app_date] => 2019-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8712 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16393103 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/393103
Methods for Synthesis of Radionuclide Complex Apr 23, 2019 Abandoned
Array ( [id] => 14682455 [patent_doc_number] => 20190240342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-08 [patent_title] => ORGANIC ANION TRANSPORTING PEPTIDE-BASED CANCER IMAGING AND THERAPY [patent_app_type] => utility [patent_app_number] => 16/390384 [patent_app_country] => US [patent_app_date] => 2019-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8395 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16390384 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/390384
ORGANIC ANION TRANSPORTING PEPTIDE-BASED CANCER IMAGING AND THERAPY Apr 21, 2019 Abandoned
Array ( [id] => 17384019 [patent_doc_number] => 20220031871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => ANTIBODIES FOR CHELATED RADIONUCLIDES AND CLEARING AGENTS [patent_app_type] => utility [patent_app_number] => 17/048072 [patent_app_country] => US [patent_app_date] => 2019-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79316 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048072 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/048072
ANTIBODIES FOR CHELATED RADIONUCLIDES AND CLEARING AGENTS Apr 15, 2019 Pending
Array ( [id] => 16853586 [patent_doc_number] => 20210154331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => CYCLOPHANES FOR LIVE-CELL IMAGING [patent_app_type] => utility [patent_app_number] => 17/047748 [patent_app_country] => US [patent_app_date] => 2019-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9649 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047748 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/047748
Cyclophanes for live-cell imaging Apr 15, 2019 Issued
Array ( [id] => 19089770 [patent_doc_number] => 11951189 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-09 [patent_title] => Targeting compounds and methods for their production [patent_app_type] => utility [patent_app_number] => 17/046053 [patent_app_country] => US [patent_app_date] => 2019-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6102 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046053 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/046053
Targeting compounds and methods for their production Apr 10, 2019 Issued
Array ( [id] => 16581548 [patent_doc_number] => 20210015950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-21 [patent_title] => FORMULATIONS AND KITS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING [patent_app_type] => utility [patent_app_number] => 17/042772 [patent_app_country] => US [patent_app_date] => 2019-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13255 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17042772 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/042772
Formulations and kits for radiotherapy and diagnostic imaging Apr 10, 2019 Issued
Array ( [id] => 14649557 [patent_doc_number] => 20190231907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => Metal Complexes with Bisphophonate or Pyrophosphate Useful as Imaging Agents [patent_app_type] => utility [patent_app_number] => 16/373803 [patent_app_country] => US [patent_app_date] => 2019-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5214 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16373803 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/373803
Metal complexes with bisphophonate or pyrophosphate useful as imaging agents Apr 2, 2019 Issued
Array ( [id] => 14621491 [patent_doc_number] => 20190224113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-25 [patent_title] => METHOD FOR PREVENTING NASOLACRIMAL DUCT OBSTRUCTION [patent_app_type] => utility [patent_app_number] => 16/371440 [patent_app_country] => US [patent_app_date] => 2019-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2809 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16371440 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/371440
Method for preventing nasolacrimal duct obstruction Mar 31, 2019 Issued
Array ( [id] => 16612229 [patent_doc_number] => 20210030882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-04 [patent_title] => USE OF BIS-IMINOBIOTIN COMPOUND FOR DRUG DELIVERY PURPOSES [patent_app_type] => utility [patent_app_number] => 17/042534 [patent_app_country] => US [patent_app_date] => 2019-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6495 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17042534 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/042534
USE OF BIS-IMINOBIOTIN COMPOUND FOR DRUG DELIVERY PURPOSES Mar 28, 2019 Abandoned
Array ( [id] => 16627542 [patent_doc_number] => 20210046195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-18 [patent_title] => FORMULATION AND METHOD OF PREPARATION [patent_app_type] => utility [patent_app_number] => 17/041759 [patent_app_country] => US [patent_app_date] => 2019-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21576 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -54 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041759 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/041759
FORMULATION AND METHOD OF PREPARATION Mar 25, 2019 Abandoned
Array ( [id] => 15604337 [patent_doc_number] => 10583209 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-10 [patent_title] => Hyperpolarized 1-13C-1,1-bis(acetoxy(methyl))-2,2'-cyclopropane as metabolic marker for MR [patent_app_type] => utility [patent_app_number] => 16/363193 [patent_app_country] => US [patent_app_date] => 2019-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 8628 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16363193 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/363193
Hyperpolarized 1-13C-1,1-bis(acetoxy(methyl))-2,2'-cyclopropane as metabolic marker for MR Mar 24, 2019 Issued
Array ( [id] => 17549395 [patent_doc_number] => 20220120736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => METHODS AND ASSAYS FOR MODULATING GENE TRANSCRIPTION BY MODULATING CONDENSATES [patent_app_type] => utility [patent_app_number] => 17/040967 [patent_app_country] => US [patent_app_date] => 2019-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 110709 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17040967 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/040967
METHODS AND ASSAYS FOR MODULATING GENE TRANSCRIPTION BY MODULATING CONDENSATES Mar 21, 2019 Pending
Array ( [id] => 16778316 [patent_doc_number] => 20210115394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => SCAFFOLD [patent_app_type] => utility [patent_app_number] => 16/981843 [patent_app_country] => US [patent_app_date] => 2019-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21587 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16981843 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/981843
SCAFFOLD Mar 18, 2019 Abandoned
Array ( [id] => 16581547 [patent_doc_number] => 20210015949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-21 [patent_title] => 177Lu-DOTA-HYNIC-iPSMA AS A THERAPEUTIC RADIOPHARMACEUTICAL TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN [patent_app_type] => utility [patent_app_number] => 16/980252 [patent_app_country] => US [patent_app_date] => 2019-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3131 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980252 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/980252
None Mar 6, 2019 Issued
Array ( [id] => 16466836 [patent_doc_number] => 20200368373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-26 [patent_title] => OPTICAL IMAGING AGENTS TARGETING INFLAMMATION [patent_app_type] => utility [patent_app_number] => 16/968272 [patent_app_country] => US [patent_app_date] => 2019-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9299 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968272 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/968272
OPTICAL IMAGING AGENTS TARGETING INFLAMMATION Feb 20, 2019 Abandoned
Array ( [id] => 16539477 [patent_doc_number] => 20200405890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => POSITRON EMISSION TOMOGRAPHY IMAGING OF ACTIVATABLE BINDING POLYPEPTIDES AND RELATED COMPOSITIONS THEREOF [patent_app_type] => utility [patent_app_number] => 16/971671 [patent_app_country] => US [patent_app_date] => 2019-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28914 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -110 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971671 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/971671
POSITRON EMISSION TOMOGRAPHY IMAGING OF ACTIVATABLE BINDING POLYPEPTIDES AND RELATED COMPOSITIONS THEREOF Feb 20, 2019 Abandoned
Array ( [id] => 16748910 [patent_doc_number] => 20210100919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-08 [patent_title] => HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS [patent_app_type] => utility [patent_app_number] => 16/970155 [patent_app_country] => US [patent_app_date] => 2019-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16367 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970155 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/970155
Heptamethine cyanines for use as fluorescent markers of the biliary and renal systems Feb 13, 2019 Issued
Array ( [id] => 14744005 [patent_doc_number] => 20190255176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-22 [patent_title] => SYSTEM FOR THE DIRECT PRODUCTION OF THERAPEUTIC YTTRIUM-90 FOR CANCER TREATMENT [patent_app_type] => utility [patent_app_number] => 16/274592 [patent_app_country] => US [patent_app_date] => 2019-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3314 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16274592 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/274592
System for the direct production of therapeutic yttrium-90 for cancer treatment Feb 12, 2019 Issued
Array ( [id] => 17719158 [patent_doc_number] => 20220211877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => COMPOUND FOR INTRAOPERATIVE MOLECULAR BIOIMAGING, METHOD OF MAKING THE SAME, USE THEREOF IN INTRAOPERATIVE MOLECULAR BIOIMAGING AND SURGICAL METHOD COMPRISING INTRAOPERATIVE MOLECULAR BIOIMAGING [patent_app_type] => utility [patent_app_number] => 16/967624 [patent_app_country] => US [patent_app_date] => 2019-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8959 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967624 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/967624
COMPOUND FOR INTRAOPERATIVE MOLECULAR BIOIMAGING, METHOD OF MAKING THE SAME, USE THEREOF IN INTRAOPERATIVE MOLECULAR BIOIMAGING AND SURGICAL METHOD COMPRISING INTRAOPERATIVE MOLECULAR BIOIMAGING Feb 5, 2019 Abandoned
Array ( [id] => 16320237 [patent_doc_number] => 10780184 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-22 [patent_title] => Fluorescent solid lipid nanoparticles composition and preparation thereof [patent_app_type] => utility [patent_app_number] => 16/263769 [patent_app_country] => US [patent_app_date] => 2019-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 13250 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16263769 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/263769
Fluorescent solid lipid nanoparticles composition and preparation thereof Jan 30, 2019 Issued
Menu